GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » Purchase Of Investment

Senhwa Biosciences (ROCO:6492) Purchase Of Investment : NT$-2,160.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Senhwa Biosciences Purchase Of Investment?

Senhwa Biosciences's purchase of investment for the three months ended in Sep. 2024 was NT$-660.00 Mil. It means Senhwa Biosciences spent NT$660.00 Mil on purchasing investments. Senhwa Biosciences's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2024 was NT$-2,160.00 Mil.

Compared with last quarter (NT$-720.00 Mil in Jun. 2024 ), Senhwa Biosciences spent less money on purchasing investments in Sep. 2024 (NT$-660.00 Mil).

Senhwa Biosciences Purchase Of Investment Historical Data

The historical data trend for Senhwa Biosciences's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senhwa Biosciences Purchase Of Investment Chart

Senhwa Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Senhwa Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -720.00 - -780.00 -720.00 -660.00

Senhwa Biosciences Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2,160.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senhwa Biosciences Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Senhwa Biosciences's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Senhwa Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Senhwa Biosciences Inc (ROCO:6492) » Definitions » Purchase Of Investment
Comparable Companies
ROCO:06891 TPE:6657 TPE:6794 TPE:6885 ROCO:6461 ROCO:1777 ROCO:6945 ROCO:6733 ROCO:8279 ROCO:4911 VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
Peihsin Road, 10th Floor, No. 225, Section 3, Hsintien District, New Taipei, TWN, 23143
Website
https://www.senhwabio.com
Senhwa Biosciences Inc is engaged in the development of new drugs and special pharmaceutical ingredients focusing on human efficacy. The company's product pipeline includes Pidnarulex (CX-5461), Silmitasertib (CX-4945), and Silmitasertib (for Moderate Covid-19). All of its revenue comes from Taiwan.

Senhwa Biosciences Headlines

No Headlines